BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hatano Y, Hirose Y, Matsunaga K, Kito Y, Yasuda I, Moriwaki H, Osada S, Yoshida K, Hara A. Combined adenomatoid tumor and well differentiated papillary mesothelioma of the omentum: Combined mesothelial tumor. Pathology International 2011;61:681-5. [DOI: 10.1111/j.1440-1827.2011.02720.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Hissong E, Graham RP, Wen KW, Alpert L, Shi J, Lamps LW. Adenomatoid tumours of the gastrointestinal tract - a case-series and review of the literature. Histopathology 2021. [PMID: 34480486 DOI: 10.1111/his.14553] [Reference Citation Analysis]
2 Parekh V, Winokur T, Cerfolio RJ, Stevens TM. Posterior Mediastinal Adenomatoid Tumor: A Case Report and Review of the Literature. Case Rep Pathol 2016;2016:6898526. [PMID: 27293940 DOI: 10.1155/2016/6898526] [Reference Citation Analysis]
3 Stevers M, Rabban JT, Garg K, Van Ziffle J, Onodera C, Grenert JP, Yeh I, Bastian BC, Zaloudek C, Solomon DA. Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42. Mod Pathol 2019;32:88-99. [PMID: 30171198 DOI: 10.1038/s41379-018-0127-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
4 Sun M, Zhao L, Weng Lao I, Yu L, Wang J. Well-differentiated papillary mesothelioma: A 17-year single institution experience with a series of 75 cases. Ann Diagn Pathol 2019;38:43-50. [PMID: 30419426 DOI: 10.1016/j.anndiagpath.2018.10.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
5 Ferreira I, De Lathouwer O, Fierens H, Theunis A, André J, de Saint Aubain N. Adenomatoid tumor of the skin: Differential diagnosis of an umbilical erythematous plaque. J Cutan Pathol 2021;48:128-32. [PMID: 32918316 DOI: 10.1111/cup.13872] [Reference Citation Analysis]
6 Nasit JG, Dhruva G. Well-Differentiated Papillary Mesothelioma of the Peritoneum. American Journal of Clinical Pathology 2014;142:233-42. [DOI: 10.1309/ajcpoto9lbb4ukwc] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
7 Erem AS, Allamaneni SS, Braverman TS. Well-Differentiated Papillary Mesothelioma with Omental Calcifications: A Case Report and Review of the Literature. Am J Case Rep 2020;21:e920487. [PMID: 31929500 DOI: 10.12659/AJCR.920487] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Nemoto H, Tate G, Kishimoto K, Saito M, Shirahata A, Umemoto T, Matsubara T, Goto T, Mizukami H, Kigawa G, Mitsuya T, Hibi K. Heterozygous loss of NF2 is an early molecular alteration in well-differentiated papillary mesothelioma of the peritoneum. Cancer Genetics 2012;205:594-8. [DOI: 10.1016/j.cancergen.2012.08.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
9 Chen X, Sheng W, Wang J. Well-differentiated papillary mesothelioma: a clinicopathological and immunohistochemical study of 18 cases with additional observation. Histopathology 2013;62:805-13. [PMID: 23530588 DOI: 10.1111/his.12089] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
10 Lao IW, Wang J. Adenomatoid tumor of the small intestine: the first case report and review of the literature. Int J Surg Pathol 2014;22:727-30. [PMID: 24891555 DOI: 10.1177/1066896914537680] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
11 Shen PR, Cen J, Qian XQ, Shen YM, Cheng XD, Wan XY. Synchronous occurrence of benign mesothelioma and adenomatoid tumor of uterus: A case report and review of literature. Medicine (Baltimore) 2019;98:e15746. [PMID: 31096539 DOI: 10.1097/MD.0000000000015746] [Reference Citation Analysis]